Email

Positions

Professor

Pediatrics-Nutrition
Baylor College of Medicine
Houston, TX US

Education

PhD from University of Cincinnati College of Medicine

06/2007 - Cincinnati, Ohio United States

Epidemiology and Biostatistics

Postdoctoral Fellowship at Cincinnati Children’s Hospital

06/2003 - Cincinnati, OH

Ophthalmology

MD from University of Khartoum School of Medicine

06/1996 - Khartoum, Sudan

Medicine and Surgery

Professional Statement

Websites

Selected Publications

• Itani A, Gronseth SL, Musaad S, Nguyen T, Mirabile Y, Beech BM "Ethical considerations for teaching with artificial intelligence: A scoping review in medical education settings." Int J Educ Technol High Educ. 2025 Nov;22(1):68. Pubmed PMID: 41255518
• Ramos MW, Gonzalez de Corcuera S, Mirabile Y, Musaad SMA, Raphael M, Gordon CM "Prevalence of postpartum depression in adolescents in an urban teen clinic." Matern Child Health J. 2025 Nov;29(11):1520-1527. Pubmed PMID: 40954403
• Musaad SMA, Mâsse LC, Beltran A, Perez O, O'Connor TM "Factor structure of food and physical activity parenting practices among US fathers by ethnicity and survey language: A cross sectional stud." BMC Public Health. 2025 Oct;25(1):3625. Pubmed PMID: 41152826
• Senawong T, Nguyen T, Mirabile YZ, Senkus KE, Musaad S, Moran NE "Carotenoid and Vitamin A intake in infants and toddlers (0-24 mo) – Sources, contribution to Vitamin A requirements, and demographic patterns (NHANES 2015-2020)." Nutr Res. 2025 Sep;143:29-43. Pubmed PMID: 41124779

Funding

Rare Organic Acidemias Research (ROAR) Consortium - #U54 HD121579

$8,163,531.00 ( 09/01/2025 - 08/31/2030 )

Grant funding from NIH/NICHD

Role: Co-Investigator (MPI: V. Reid Sutton & Lindsay Burrage, BCM) 1) Perform collaborative, multi-site, clinical and translational research in organic acidemias that will prioritize patient/community concerns, enhance knowledge, improve care, and advance clinical trial readiness; 2) Train and attract a cohort of investigators in organic acidemias research; 3) Serve as a hub for the development of innovative new strategies for managing and treating organic acidemias; and 4) Collaborate with two patient advocacy groups, the RDCRN Data Management and Coordinating Center, and other RDCRN consortia to advance care and educate patients, families, and healthcare providers across a broad spectrum of rare diseases. (Admin Core)

Comparative Feasibility and Effectiveness of Medically Tailored Meals Approaches for Pediatric End Stage Kidney Disease - #R01 DK141577

$918,998.00 ( 09/09/2025 - 06/30/2026 )

Grant funding from NIH/NIDDK

Role: Co-Investigator (MPI: Jayna Dave & Elizabeth Onugha, BCM) The purpose of our study is to conduct a short-term proof-of-concept 2-arm randomized comparative effectiveness trial to acquire preliminary data regarding feasibility and the impact of two medically tailored meals approaches - the culinary medicine-based MTMs vs. pre-prepared MTMs - for ESKD pediatric patients.

Addressing Clinical Trial Readiness in Osteogenesis Imperfecta Using Longitudinal Data from the Brittle Bone Disorders Consortium

$201,643.00 ( 07/01/2025 - 07/01/2026 )

Grant funding from Ultragenyx Pharmaceutical

Role: Co-Investigator (PI: Sandesh Nagamani, BCM) This study will characterize the key disease-specific endpoints longitudinally for pediatric and adult patients with OI types I, III, and IV. Data gathered from this study has the potential to inform design and also to serve as an external control data for Ultragenyx’s future interventional trials. Most importantly, the data from the project can provide comprehensive clinical trial readiness information.

The AGEIS Study

$213,624.00 ( 07/01/2025 - 06/30/2026 )

Grant funding from Indiana University Foundation

Role: Co-Investigator (PI: Molly Rosenberg, IU) Conduct creative research related to COVID-19 that leads to better outcomes for humans who have had COVID-19. Better understand the mechanisms and ways in which COVID-19 infection leads to long-term alterations in health and well-being.